Page last updated: 2024-11-02

piracetam and Chronic Fatigue and Immune Dysfunction Syndrome

piracetam has been researched along with Chronic Fatigue and Immune Dysfunction Syndrome in 2 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Research Excerpts

ExcerptRelevanceReference
"We studied efficacy and tolerability of the combined drug omaron (25 mg of cinnarizine and 400 mg of piracetam in one tablet) in patients with multiple sclerosis."5.14[Omaron in the complex treatment of patients with multiple sclerosis]. ( Batysheva, TT; Boĭko, AN; Kamchatnov, PR; Popova, NF; Riabukhina, OV; Zaĭtsev, KA, 2010)
"In patients with encephalopathies, chronic fatigue syndrome was directly associated with the severity of depression."2.73Characteristics of the formation of chronic fatigue syndrome and approaches to its treatment in young patients with focal brain damage. ( Batysheva, TT; Boiko, AN; Gusev, EI; Manevich, TM; Matvievskaya, OV, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Popova, NF1
Kamchatnov, PR1
Riabukhina, OV1
Batysheva, TT2
Zaĭtsev, KA1
Boĭko, AN2
Matvievskaya, OV1
Manevich, TM1
Gusev, EI1

Trials

2 trials available for piracetam and Chronic Fatigue and Immune Dysfunction Syndrome

ArticleYear
[Omaron in the complex treatment of patients with multiple sclerosis].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2010, Volume: 110, Issue:11 Pt 1

    Topics: Adult; Cinnarizine; Drug Combinations; Fatigue Syndrome, Chronic; Female; Humans; Male; Middle Aged;

2010
Characteristics of the formation of chronic fatigue syndrome and approaches to its treatment in young patients with focal brain damage.
    Neuroscience and behavioral physiology, 2007, Volume: 37, Issue:3

    Topics: Adult; Brain Injuries; Calcium Channel Blockers; Cinnarizine; Drug Therapy, Combination; Fatigue Syn

2007